What is an RSV Vaccine?

Respiratory syncytial virus, or RSV leads to approximately 60,000-120,000 hospitalizations among adults 65 and older every year. Arexvy is a single-dose vaccine approved for the prevention of lower respiratory tract disease caused by RSV.

• Recommended for all patients 75+.
• For ages 60-74, please discuss with a pharmacist or health care provider if this vaccine is right for you.
• Covered by many insurance plans.
• No prescription necessary.

What is RSV?

RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover from RSV in 1-2 weeks, but it can cause serious illness. Older adults and infants are more likely to develop severe RSV.

Who should get vaccinated for RSV?

 Adults 60 years of age and older may receive a single dose of RSV vaccine.

To learn more, visit: https://www.cdc.gov/rsv/index.html